Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

Researchers at Wakayama Medical University in Japan have discovered that amyloid-β deposits disrupt the formation of the ...

The trial seeks to find an easier and less expensive way to detect a disease that affects 1 in 9 people over the age of 65.

Panelists discuss how identifying candidates for anti-amyloid therapy requires precise evaluation of disease stage, cognitive ...

A link between abnormal blood levels of amyloid -- a protein associated with Alzheimer's disease -- and subtle changes in brain microstructures on a type of MRI could lead to a new way to detect ...

Plasma phosphorylated tau 217 (p-tau217) outperformed p-tau181, p-tau231, and other blood-based biomarkers to identify which patients might benefit most from anti-amyloid Alzheimer's drugs, a cohort ...

Managing Alzheimer’s disease requires an intricate understanding of available treatments. Michelle Sorweid, DO, MPH, sheds light on anti-amyloid antibody therapy, how it works, and what patients are ...

If you are like a lot of people, you might be anxious about the risk of getting dementia as you age. The lifetime risk of ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta plaques associated with Alzheimer's disease, performed so well in a phase Ib/IIa ...